Human Immunodeficiency Virus Proteins Mimic Human T Cell Receptors Inducing Cross-Reactive Antibodies.

Robert Root-Bernstein
Author Information
  1. Robert Root-Bernstein: Department of Physiology, Michigan State University, 567 Wilson Road, Room 2201, East Lansing, MI 48824 USA. rootbern@msu.edu. ORCID

Abstract

Human immunodeficiency virus (HIV) hides from the immune system in part by mimicking host antigens, including human leukocyte antigens. It is demonstrated here that HIV also mimics the V-β-D-J-β of approximately seventy percent of about 600 randomly selected human T cell receptors (TCR). This degree of mimicry is greater than any other human pathogen, commensal or symbiotic organism studied. These data suggest that HIV may be evolving into a commensal organism just as simian immunodeficiency virus has done in some types of monkeys. The gp120 envelope protein, Nef protein and Pol protein are particularly similar to host TCR, camouflaging HIV from the immune system and creating serious barriers to the development of safe HIV vaccines. One consequence of HIV mimicry of host TCR is that antibodies against HIV proteins have a significant probability of recognizing the corresponding TCR as antigenic targets, explaining the widespread observation of lymphocytotoxic autoantibodies in acquired immunodeficiency syndrome (AIDS). Quantitative enzyme-linked immunoadsorption assays (ELISA) demonstrated that every HIV antibody tested recognized at least one of twelve TCR, and as many as seven, with a binding constant in the 10 to 10 m range. HIV immunity also affects microbiome tolerance in ways that correlate with susceptibility to specific opportunistic infections.

Keywords

References

  1. AIDS Res Hum Retroviruses. 1993 Oct;9(10):939-44 [PMID: 7506553]
  2. ISME J. 2014 Sep;8(9):1781-93 [PMID: 24599071]
  3. J Infect Dis. 2011 Sep 15;204(6):902-11 [PMID: 21849287]
  4. Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5980-5 [PMID: 24711416]
  5. Perspect Biol Med. 1990 Summer;33(4):480-500 [PMID: 2216658]
  6. Br J Haematol. 1995 Nov;91(3):525-34 [PMID: 8555050]
  7. Front Pediatr. 2014 Aug 19;2:85 [PMID: 25191648]
  8. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10849-53 [PMID: 7971973]
  9. Science. 2015 Aug 14;349(6249):aab1253 [PMID: 26229114]
  10. Blood Coagul Fibrinolysis. 2008 Oct;19(7):739-740 [PMID: 18832897]
  11. Science. 1991 Sep 6;253(5024):1138-40 [PMID: 1909456]
  12. J Immunol. 1999 Jun 15;162(12):7569-77 [PMID: 10358214]
  13. Clin Immunol Immunopathol. 1991 Feb;58(2):163-80 [PMID: 1985795]
  14. Arch Intern Med. 1989 Jul;149(7):1541-4 [PMID: 2742428]
  15. J Infect Dis. 1993 Dec;168(6):1396-403 [PMID: 8245524]
  16. J Neurovirol. 1995 Dec;1(5-6):381-90 [PMID: 9222381]
  17. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 15;17(5):385-90 [PMID: 9562039]
  18. J Exp Med. 1988 Mar 1;167(3):914-23 [PMID: 3127528]
  19. J Clin Invest. 1959 Nov;38:1996-2016 [PMID: 13799922]
  20. AIDS Rev. 2008 Jul-Sep;10(3):162-71 [PMID: 18820718]
  21. J Virol. 1994 Oct;68(10):6262-9 [PMID: 8083966]
  22. Med Hypotheses. 1995 Jan;44(1):20-7 [PMID: 7776897]
  23. Front Biosci. 2004 Jan 01;9:550-64 [PMID: 14766390]
  24. J Exp Med. 1991 Jul 1;174(1):53-62 [PMID: 1711567]
  25. Immunol Lett. 1991 May;28(2):91-6; discussion 97-9 [PMID: 1885213]
  26. Hum Vaccin Immunother. 2014;10(12):3570-5 [PMID: 25483703]
  27. Ann N Y Acad Sci. 1984;437:177-83 [PMID: 6100000]
  28. Protein Pept Lett. 2015;22(8):672-80 [PMID: 25751267]
  29. Am J Reprod Immunol. 2014 Jun;71(6):531-6 [PMID: 24661438]
  30. Symbiosis. 1991;11:93-101 [PMID: 11538111]
  31. Expert Rev Vaccines. 2016 May;15(5):607-17 [PMID: 26588466]
  32. Biosystems. 1992;27(1):53-62 [PMID: 1391691]
  33. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3060-4 [PMID: 1901653]
  34. Nat Rev Immunol. 2004 Feb;4(2):123-32 [PMID: 15040585]
  35. Nat Rev Immunol. 2008 Mar;8(3):231-8 [PMID: 18301425]
  36. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6364-8 [PMID: 3476953]
  37. Cell Host Microbe. 2014 Aug 13;16(2):215-226 [PMID: 25121750]
  38. Immunol Res. 2000;22(1):61-6 [PMID: 10945227]
  39. Curr Opin Immunol. 1989 Apr;1(4):753-6 [PMID: 2679729]
  40. Curr Opin Immunol. 2011 Feb;23(1):21-8 [PMID: 21123040]
  41. Res Microbiol. 2017 Nov - Dec;168(9-10):859-864 [PMID: 28257809]
  42. Vox Sang. 1993;65(1):10-7 [PMID: 8103248]
  43. Clin Immunol Immunopathol. 1986 Dec;41(3):305-13 [PMID: 2946499]
  44. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1091-8 [PMID: 1503823]
  45. Curr HIV Res. 2006 Apr;4(2):177-90 [PMID: 16611056]
  46. Hum Immunol. 1992 May;34(1):31-8 [PMID: 1399720]
  47. Curr Pharm Des. 2006;12(16):2017-30 [PMID: 16787245]
  48. AIDS Res Hum Retroviruses. 1995 Aug;11(8):971-80 [PMID: 7492444]
  49. Sci Immunol. 2016 Jul 29;1(1):aag0851 [PMID: 28783677]
  50. Clin Exp Immunol. 2005 Aug;141(2):338-56 [PMID: 15996199]
  51. Virology. 1998 Jun 20;246(1):53-62 [PMID: 9656993]
  52. J Virol. 1991 Mar;65(3):1370-6 [PMID: 1704927]
  53. Mol Pathol. 2003 Feb;56(1):11-8 [PMID: 12560456]
  54. Retrovirology. 2012 Jan 16;9:6 [PMID: 22248111]
  55. Eur J Immunol. 1987 Dec;17(12):1793-8 [PMID: 2446880]
  56. Eur J Immunol. 1993 Aug;23(8):2016-21 [PMID: 8344367]
  57. Nature. 1991 Oct 17;353(6345):622-7 [PMID: 1656276]
  58. Autoimmun Rev. 2004 Nov;3(7-8):530-40 [PMID: 15546802]
  59. C R Biol. 2010 Aug;333(8):608-12 [PMID: 20688281]
  60. J Cell Biol. 2003 Aug 4;162(3):425-34 [PMID: 12900394]
  61. J Virol. 1993 Aug;67(8):4639-50 [PMID: 8043040]
  62. Immunol Today. 1999 Feb;20(2):66-71 [PMID: 10098324]
  63. PLoS One. 2007 Sep 05;2(9):e823 [PMID: 17786195]
  64. Front Biosci (Elite Ed). 2011 Jun 01;3(4):1385-400 [PMID: 21622144]
  65. ISRN AIDS. 2013 Aug 12;2013:954806 [PMID: 24052891]
  66. Nature. 2013 Nov 21;503(7476):402-405 [PMID: 24196705]
  67. J Clin Invest. 2002 Oct;110(8):1133-9 [PMID: 12393849]
  68. Nature. 1991 Oct 3;353(6343):393 [PMID: 1815549]
  69. Immunol Res. 2016 Jun;64(3):641-52 [PMID: 26676359]
  70. Daru. 2012 Oct 15;20(1):53 [PMID: 23351891]
  71. J Infect Dis. 2002 Aug 15;186(4):477-85 [PMID: 12195374]
  72. J Virol. 1993 Dec;67(12):7711-5 [PMID: 8230494]
  73. Lancet Infect Dis. 2009 Feb;9(2):118-29 [PMID: 19179227]
  74. Am J Med. 1992 Jun;92(6):681-5 [PMID: 1605150]
  75. Blood. 2005 Jul 15;106(2):572-6 [PMID: 15774614]
  76. Mutat Res. 2005 Nov 11;579(1-2):133-48 [PMID: 16054658]
  77. Curr Drug Targets. 2004 Jan;5(1):71-88 [PMID: 14738219]
  78. J Clin Invest. 1989 Apr;83(4):1430-5 [PMID: 2467924]
  79. J Theor Biol. 2000 Feb 7;202(3):213-29 [PMID: 10660476]
  80. J Clin Virol. 2004 Dec;31 Suppl 1:S16-25 [PMID: 15567090]
  81. Bioessays. 2016 Nov;38(11):1068-1083 [PMID: 27594308]
  82. J Virol. 1988 Jun;62(6):2107-14 [PMID: 2452899]
  83. Mol Cell. 2004 Jan 30;13(2):179-90 [PMID: 14759364]
  84. AIDS Res. 1983-1984;1(2):107-20 [PMID: 6100776]
  85. J Infect Dis. 2003 Feb 1;187(3):385-97 [PMID: 12552422]
  86. J Autoimmun. 2001 May;16(3):287-91 [PMID: 11334494]
  87. Autoimmunity. 2004 May;37(3):203-10 [PMID: 15497453]
  88. FEMS Microbiol Rev. 2013 Sep;37(5):762-92 [PMID: 23789590]
  89. Blood. 1992 Jul 1;80(1):162-9 [PMID: 1611083]
  90. J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):119-28 [PMID: 26656786]
  91. Immunol Cell Biol. 2011 Mar;89(3):375-87 [PMID: 21301479]
  92. Vaccine. 2005 Mar 18;23(17-18):2160-3 [PMID: 15755587]
  93. Front Microbiol. 2014 Oct 06;5:502 [PMID: 25339942]
  94. Rev Med Virol. 2009 Sep;19(5):301-11 [PMID: 19650156]
  95. Res Immunol. 1991 Sep;142(7):519-23 [PMID: 1812547]
  96. Med Hypotheses. 1994 Dec;43(6):361-71 [PMID: 7739408]
  97. Autoimmunity. 1989;3(3):201-12 [PMID: 2491628]
  98. J Virol. 1985 Aug;55(2):274-80 [PMID: 2410626]
  99. Sci Transl Med. 2016 Apr 27;8(336):336ra62 [PMID: 27122615]
  100. J Virol. 2005 Jan;79(1):341-52 [PMID: 15596828]
  101. Biochem Soc Trans. 1995 Aug;23(3):471S [PMID: 8566367]
  102. J Immunol. 1989 Oct 15;143(8):2677-83 [PMID: 2677144]
  103. Adv Exp Med Biol. 1995;383:211-22 [PMID: 8644504]
  104. IDrugs. 2009 Jul;12(7):435-9 [PMID: 19579164]
  105. Mucosal Immunol. 2017 Nov;10(6):1480-1490 [PMID: 28401934]
  106. Genetica. 1995;95(1-3):111-32 [PMID: 7744256]
  107. J Vet Med Sci. 2015 Nov;77(11):1379-83 [PMID: 26062435]
  108. Thromb Res. 2000 May 15;98(4):343-6 [PMID: 10822081]

MeSH Term

Acquired Immunodeficiency Syndrome
Animals
Autoimmunity
Cross Reactions
HIV
Human Immunodeficiency Virus Proteins
Humans
Microbiota
Molecular Mimicry
Proteomics
Receptors, Antigen, T-Cell

Chemicals

Human Immunodeficiency Virus Proteins
Receptors, Antigen, T-Cell

Word Cloud

Created with Highcharts 10.0.0HIVTCRimmunodeficiencyHumanhosthumanmimicryproteinvirusimmunesystemantigensdemonstratedalsoTcommensalorganismantigeniclymphocytotoxicautoantibodiesacquiredsyndrome10microbiometolerancehidespartmimickingincludingleukocytemimicsV-β-D-J-βapproximatelyseventypercent600randomlyselectedcellreceptorsdegreegreaterpathogensymbioticstudieddatasuggestmayevolvingjustsimiandonetypesmonkeysgp120envelopeNefPolparticularlysimilarcamouflagingcreatingseriousbarriersdevelopmentsafevaccinesOneconsequenceantibodiesproteinssignificantprobabilityrecognizingcorrespondingtargetsexplainingwidespreadobservationAIDSQuantitativeenzyme-linkedimmunoadsorptionassaysELISAeveryantibodytestedrecognizedleastonetwelvemanysevenbindingconstantmrangeimmunityaffectswayscorrelatesusceptibilityspecificopportunisticinfectionsImmunodeficiencyVirusProteinsMimicCellReceptorsInducingCross-ReactiveAntibodiesautoholoimmunityautoimmunityholoimmunity

Similar Articles

Cited By